GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

91

Single-Cell Multiomics Maps the Immune Storm Driving HBV-ACLF Progression- Gut Feb.26

This longitudinal single-cell multiomics study provides a detailed immune roadmap of HBV-related acute-on-chronic liver failure (HBV-ACLF), a syndrome marked by profound immune dysregulation and high short-term mortality. Using...

92

LECT2–PHB2 Signaling: A New Target in Alcohol-Associated Hepatitis

Alcohol-associated hepatitis (AH) remains a high-mortality condition with limited effective therapies. A central driver of disease progression is excessive hepatic inflammation, particularly massive neutrophil infiltration, triggered by cytokine...

93

ER Stress as the Molecular Bridge Between MASH and Hepatocellular Carcinoma- Hepatology Feb.26

Metabolic dysfunction–associated steatohepatitis (MASH) is rapidly becoming a leading driver of hepatocellular carcinoma (HCC). This comprehensive review highlights endoplasmic reticulum (ER) stress and the unfolded protein response (UPR)...

94

Targeting Caspase-8 to Slow MASH Progression- Hepatology Feb.26

Metabolic dysfunction–associated steatohepatitis (MASH) is driven by oxidative stress, hepatocyte injury, inflammation, and fibrosis. Activation of the c-Jun N-terminal kinase (JNK) pathway has long been associated with MASH,...

95

Macrotrabecular HCC- Hepatology 26

Hepatocellular carcinoma (HCC) displays marked histologic heterogeneity that reflects distinct biological behaviors and treatment responses. Among recognized variants, macrotrabecular–massive HCC (MT-HCC) represents a particularly aggressive subtype characterized by...

96

A Whole-Blood Bioartificial Liver in Preclinical Models- J Hepatol Feb.26

Acute-on-chronic liver failure (ACLF) and acute liver failure (ALF) are life-threatening conditions marked by severe hepatic dysfunction combined with overwhelming systemic inflammation. Mortality remains extremely high because no...

97

Adipose Macrophage sEVs in MASH: Promise With Mechanistic Gaps- Gastroenterology Feb.26

Introduction Metabolically–dysfunction–associated steatohepatitis (MASH) is increasingly recognised as a multiorgan disease, with pathogenic signalling extending beyond the liver. Rohm et al. propose an intriguing extrahepatic mechanism: adipose tissue...

98

LKB1 Loss Primes the Serrated Pathway in the Intestine- Gastroenterology Feb.26

Introduction Peutz–Jeghers syndrome (PJS) is a hereditary cancer-predisposition condition caused by germline mutations in LKB1 (STK11). While patients are known to have an increased risk of gastrointestinal cancers,...

99

Envbiotics-Front. Med. 2026

What Are Envbiotics? Envbiotics is a term that encapsulates the idea of regulating and optimising gut microbiota indirectly by focusing on the environmental conditions of the gut rather...

100

What is serum Metabolomic Signature, Summary of the results (AP&T) - Jan,2026

It seems you're asking about the concept of serum metabolomic signatures and their summarized results as detailed in the study mentioned in the context. While the specific reference...

Previous
19101115
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer